DNA, FDA Approval, Gene Editing and Genetic Disease

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

DNA

FDA Approval

Gene Editing

Genetic Disease

Lyfgenia and Casgevy Become First FDA-Approved Gene Therapies for Sickle Cell Disease

XTalks

DECEMBER 13, 2023

The CRISPR system is dubbed to be molecular “scissors” that can cut out parts of genes that are abnormal, deactivating or replacing them with new strands of normal DNA. This has tremendous potential for curing diseases that are caused by faulty/mutated genes. Both therapies will be available in early 2024.

Gene Therapy

Gene Therapy FDA Approval Gene In-Vivo

Key Trends in the Life Sciences to Look Forward to in 2022

XTalks

DECEMBER 22, 2021

The gene-editing tool CRISPR edits DNA using specialized strands of guide RNA and endogenous cellular mechanisms of RNA interference. Non-invasive or minimally invasive medical devices that can diagnose, monitor and treat disease is entering a promising era, and will be a key life science trend next year.

Life Science

Life Science RNA Vaccination Vaccine

Clinical Research Informer

Lyfgenia and Casgevy Become First FDA-Approved Gene Therapies for Sickle Cell Disease

Key Trends in the Life Sciences to Look Forward to in 2022

Stay Connected